caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1780772947

Yong LinM.D.

Internal MedicineNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Yong Lin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 14 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
2451,385
Calvin Lo
Diagnostic Radiology · New York, NY
2343
Jian Liang
Podiatry · New York, NY
1974
Michael Liou
Interventional Cardiology · New York, NY
1775
Heather Osborne
Diagnostic Radiology · New York, NY
1728
TRASI, SUNIL1529
NPI 11846731051559
Raymond Yung
Otolaryngology · New York, NY
1428
Victoria Zhang
Physical Medicine and Rehabilitation · New York, NY
1440
CHEN, PETER1331
Kenneth Tam
Internal Medicine · New York, NY
1325
Barbara Kuang
Diagnostic Radiology · New York, NY
1217
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
115
Unique beneficiaries
—
Total services
216
Distinct HCPCS
5
Medicare payment
$16K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 7,864 Internal Medicine providers in NY — below median (cohort median 552).
PRESCRIBING · PART D · 2024
Total Rx claims
30,624
Beneficiaries
—
Total drug cost
$4.4M
Distinct drugs
140
Brand share
23.8%
Top prescribed drugs
Atorvastatin Calcium2,639 claims
Amlodipine Besylate2,563 claims
Icosapent Ethyl2,240 claims
Losartan Potassium2,208 claims
Diclofenac Epolamine1,971 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
38
By payment type
Food and Beverage$2K